Red blood cell vesiculation in hereditary hemolytic anemia

Frontiers in Physiology

Volumn 4 DEC, Issue , 2013, Pages

  Alaarg, Amr ^a,b   Schiffelers, Raymond M ^a,b   Van Solinge, Wouter W ^a   Van Wijk, Richard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Enzyme disorder; Erythrocyte; Hemoglobinopathy; Hemolytic anemia; Membrane disorder; Microvesicle; Red blood cell

Indexed keywords

ANKYRIN; HEMOGLOBIN; NANOPARTICLE;

BIOCHEMISTRY; CELL STIMULATION; CELL VACUOLE; CYTOMETRY; ELLIPTOCYTOSIS; ENZYME DEFICIENCY; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE STRUCTURE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEREDITARY HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HUMAN; NANOANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PYRUVATE KINASE DEFICIENCY; RED CELL VESICULATION; REVIEW; SICKLE CELL ANEMIA; STOMATOCYTOSIS; THALASSEMIA;

EID: 84891705954     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00365     Document Type: Review

References (135)

1. Al Salem, A. H. (2011). Splenic complications of sickle cell anemia and the role of splenectomy. ISRN Hematol. 2011, 864257. doi: 10.5402/2011/864257.
2. Albuisson, J., Murthy, S. E., Bandell, M., Coste, B., Louis-Dit-Picard, H., Mathur, J., et al. (2013). Dehydrated Hereditary Stomatocytosis Linked to Gain-of-Function Mutations in Mechanically Activated PIEZO1 Ion Channels. Nat. Commun. 4, 1884. doi: 10.1038/ncomms2899.
3. Allan, D., Limbrick, A., Thomas, P., and Westerman, M. (1982). Release of Spectrin-Free Spicules on Reoxygenation of Sickled Erythrocytes. Nature. 295, 612-613. doi: 10.1038/295612a0.
4. Almizraq, R., Tchir, J. D., Holovati, J. L., and Acker, J. P. (2013). Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 53, 2258-2267. doi: 10.1111/trf.12080.
5. Andolfo, I., Alper, S. L., De Franceschi, L., Auriemma, C., Russo, R., De Falco, L., et al. (2013). Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 121, 3925-35, S1-S12. doi: 10.1182/blood-2013-02-482489.
6. Baerlocher, G., Beer, J., Owen, G., Meiselman, H., and Reinhart, W. (1997). The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology. Br. J. Haematol. 99, 426-432. doi: 10.1046/j.1365-2141.1997.4003212.x.
7. Barteneva, N. S., Fasler-Kan, E., Bernimoulin, M., Stern, J. N., Ponomarev, E. D., Duckett, L., et al. (2013). Circulating microparticles: square the circle. BMC Cell Biol. 14:23. doi: 10.1186/1471-2121-14-23.
8. Bastos-Amador, P., Royo, F., Gonzalez, E., Conde-Vancells, J., Palomo-Diez, L., Borras, F. E., et al. (2012). Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J. Proteomics. 75, 3574-3584. doi: 10.1016/j.jprot.2012.03.054.
9. Betz, T., Lenz, M., Joanny, J., and Sykes, C. (2009). ATP-dependent mechanics of red blood cells. Proc. Natl. Acad. Sci. U.S.A. 106, 15320-15325. doi: 10.1073/pnas.0904614106.
10. Bevers, E., Comfurius, P., Dekkers, D., and Zwaal, R. (1999). Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta. 1439, 317-330. doi: 10.1016/S1388-1981(99)00110-9.
11. Bevers, E., Wiedmer, T., Comfurius, P., Shattil, S., Weiss, H., Zwaal, R., et al. (1992). Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of scott syndrome. Blood 79, 380-388.
12. Biro, E., Sturk-Maquelin, K. N., Vogel, G. M., Meuleman, D. G., Smit, M. J., Hack, C. E., et al. (2003). Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost. 1, 2561-2568. doi: 10.1046/j.1538-7836.2003.00456.x.
13. Bosman, G. J., Lasonder, E., Groenen-Dopp, Y. A., Willekens, F. L., and Werre, J. M. (2012). The Proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J. Proteomics. 76(Spec. No.), 203-210. doi: 10.1016/j.jprot.2012.05.031.
14. Bosman, G. J., Lasonder, E., Groenen-Dopp, Y. A., Willekens, F. L., Werre, J. M., and Novotny, V. M. (2010). Comparative proteomics of erythrocyte aging in vivo and in vitro. J. Proteomics. 73, 396-402. doi: 10.1016/j.jprot.2009.07.010.
15. Bosman, G. J., Lasonder, E., Luten, M., Roerdinkholder-Stoelwinder, B., Novotny, V. M., Bos, H., et al. (2008). The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48, 827-835. doi: 10.1111/j.1537-2995.2007.01630.x.
16. Brewer, G., Brewer, L., and Prasad, A. (1977). Suppression of irreversibly sickled erythrocytes by zinc therapy in sickle cell anemia. J. Lab. Clin. Med. 90, 549-554.
17. Brown, M., and Wittwer, C. (2000). Flow cytometry: principles and clinical applications in hematology. Clin. Chem. 46, 1221-1229.
18. Bruce, L. J. (2009). Hereditary stomatocytosis and cation-leaky red cells-recent developments. Blood Cells Mol. Dis. 42, 216-222. doi: 10.1016/j.bcmd.2009.01.014.
19. Bruce, L. J., Robinson, H. C., Guizouarn, H., Borgese, F., Harrison, P., King, M. J., et al. (2005). Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat. Genet. 37, 1258-1263. doi: 10.1038/ng1656.
20. Bucki, R., Bachelot-Loza, C., Zachowski, A., Giraud, F., and Sulpice, J. (1998). Calcium induces phospholipid redistribution and microvesicle release in human erythrocyte membranes by independent pathways. Biochemistry (NY) 37, 15383-15391. doi: 10.1021/bi9805238.
21. Bütikofer, P., Brodbeck, U., and Ott, P. (1987). Modulation of erythrocyte vesiculation by amphiphilic drugs. Biochim. Biophys. Acta. 901, 291-295. doi: 10.1016/0005-2736(87)90126-X.
22. Bütikofer, P., Lin, Z. W., Kuypers, F. A., Scott, M. D., Xu, C. M., Wagner, G. M., et al. (1989). Chlorpromazine inhibits vesiculation, alters phosphoinositide turnover and changes deformability of ATP-Depleted RBCs. Blood 73, 1699-1704.
23. Canellini, G., Rubin, O., Delobel, J., Crettaz, D., Lion, N., and Tissot, J. D. (2012). Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. Blood Transfus. 10(Suppl. 2), s39-s45. doi: 10.2450/2012.007S.
24. Cappellini, M., and Fiorelli, G. (2008). Glucose-6-phosphate dehydrogenase deficiency. Lancet 371, 64-74. doi: 10.1016/S0140-6736(08)60073-2.
25. Casale, M., and Perrotta, S. (2011). Splenectomy for hereditary spherocytosis: complete, partial or not at all? Expert Rev. Hematol. 4, 627-635. doi: 10.1586/EHM.11.51.
26. Chaichompoo, P., Kumya, P., Khowawisetsut, L., Chiangjong, W., Chaiyarit, S., Pongsakul, N., et al. (2012). Characterizations and proteome analysis of platelet-free plasma-derived microparticles in beta-thalassemia/hemoglobin E patients. J. Proteomics. 76(Spec. No.), 239-250. doi: 10.1016/j.jprot.2012.06.004.
27. Chasis, J., Agre, P., and Mohandas, N. (1988). Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis. J. Clin. Invest. 82, 617-623. doi: 10.1172/JCI113640.
28. Chaurio, R. A., Janko, C., Munoz, L. E., Frey, B., Herrmann, M., and Gaipl, U. S. (2009). Phospholipids: key players in apoptosis and immune regulation. Molecules 14, 4892-4914. doi: 10.3390/molecules14124892.
29. Clark, M. R., Mohandas, N., and Shohet, S. B. (1983). Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood 61, 899-910.
30. Cluitmans, J. C., Hardeman, M. R., Dinkla, S., Brock, R., and Bosman, G. J. (2012). Red blood cell deformability during storage: towards functional proteomics and metabolomics in the blood Bank. Blood Transfus. 10(Suppl 2), s12-18. doi: 10.2450/2012.004S.
31. Da Costa, L., Galimand, J., Fenneteau, O., and Mohandas, N. (2013). Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev. 27, 167-178. doi: 10.1016/j.blre.2013.04.003.
32. Daleke, D. L. (2008). Regulation of phospholipid asymmetry in the erythrocyte membrane. Curr. Opin. Hematol. 15, 191-195. doi: 10.1097/MOH.0b013e3282f97af7.
33. Davis, B. H. (2001). Diagnostic utility of red cell flow cytometric analysis. Clin. Lab. Med. 21, 829-840.
34. de Jong, K., Larkin, S., Styles, L., Bookchin, R., and Kuypers, F. (2001). Characterization of the Phosphatidylserine-exposing subpopulation of sickle cells. Blood 98, 860-867. doi: 10.1182/blood.V98.3.860.
35. de Jong, K., Larkin, S. K., Eber, S., Franck, P. F., Roelofsen, B., and Kuypers, F. A. (1999). Hereditary spherocytosis and elliptocytosis erythrocytes show a normal transbilayer phospholipid distribution. Blood. 94, 319-325.
36. de Vooght, K. M., Lau, C., de Laat, P. P., van Wijk, R., van Solinge, W. W., and Schiffelers, R. M. (2013). Extracellular vesicles in the circulation: are erythrocyte microvesicles a confounder in the plasma haemoglobin assay? Biochem. Soc. Trans. 41, 288-292. doi: 10.1042/BST20120254.
37. Dhaliwal, G., Cornett, P. A., and Tierney, L. M. Jr., (2004). Hemolytic anemia. Am. Fam. Physician. 69, 2599-2606.
38. Donadee, C., Raat, N., Kanias, T., Tejero, J., Lee, J., Kelley, E., et al. (2011). Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124, 465-476. doi: 10.1161/CIRCULATIONAHA.110.008698.
39. Eber, S. W., Armbrust, R., and Schroter, W. (1990). Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J. Pediatr. 117, 409-416. doi: 10.1016/S0022-3476(05)81081-9.
40. EL Andaloussi, S., Mager, I., Breakefield, X. O., and Wood, M. J. (2013). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347-357. doi: 10.1038/nrd3978.
41. Flatt, J. F., Guizouarn, H., Burton, N. M., Borgese, F., Tomlinson, R. J., Forsyth, R. J., et al. (2011). Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood 118, 5267-5277. doi: 10.1182/blood-2010-12-326645.
42. Fourcade, O., Simon, M., Viodé C, Rugani, N., Leballe, F., Ragab, A., et al. (1995). Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80, 919-927. doi: 10.1016/0092-8674(95)90295-3.
43. Gallagher, P. (2004). Hereditary elliptocytosis: spectrin and protein 4.1R. Semin. Hematol. 41, 142-164. doi: 10.1053/j.seminhematol.2004.01.003.
44. Gallagher, P. G., Chang, S. H., Rettig, M. P., Neely, J. E., Hillery, C. A., Smith, B. D., et al. (2003). Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 101, 4625-4627. doi: 10.1182/blood-2001-12-0329.
45. Girodon, F., Garcon, L., Bergoin, E., Largier, M., Delaunay, J., Feneant-Thibault, M., et al. (2008). Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br. J. Haematol. 140, 468-470. doi: 10.1111/j.1365-2141.2007.06944.x.
46. Graham, T. (2004). Flippases and vesicle-mediated protein transport. Trends Cell Biol. 14, 670-677. doi: 10.1016/j.tcb.2004.10.008.
47. Greenwalt, T. J. (2006). The how and why of exocytic vesicles. Transfusion 46, 143-152. doi: 10.1111/j.1537-2995.2006.00692.x.
48. Gregg, X. T., and Prchal, J. T. (2008). "Red blood cell enzymopathies," in Hematology: Basic Principles and Practice, eds R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, L. E. Silberstein, P. McGlave, and H. Heslop (Philadelphia, PA: Churchill Livingstone), 611-622.
49. Gurbuz, N., Yalcin, O., Aksu, T., and Baskurt, O. (2004). The Relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals. Clin. Hemorheol. Microcirc. 31, 235-242.
50. Hardeman, M. R., Dobbe, J. G., and Ince, C. (2001). The Laser-assisted optical rotational cell analyzer (LORCA) as red blood cell aggregometer. Clin. Hemorheol. Microcirc. 25, 1-11.
51. Harding, C., Heuser, J., and Stahl, P. (1983). Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329-339. doi: 10.1083/jcb.97.2.329.
52. Hebbel, R. (1991). Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 77, 214-237.
53. Hugel, B., Martínez, M. C., Kunzelmann, C., and Freyssinet, J. M. (2005). Membrane microparticles: two sides of the coin. Physiology 20, 22-27. doi: 10.1152/physiol.00029.2004.
54. Johnson, R. M., Panchoosingh, H., Goyette, G. Jr., and Ravindranath, Y. (1999). Increased erythrocyte deformability in fetal erythropoiesis and in erythrocytes deficient in glucose-6-phosphate dehydrogenase and other glycolytic enzymes. Pediatr. Res. 45, 106-113. doi: 10.1203/00006450-199901000-00018.
55. Johnson, R. M., and Ravindranath, Y. (1996). Osmotic scan ektacytometry in clinical diagnosis. J. Pediatr. Hematol. Oncol. 18, 122-129. doi: 10.1097/00043426-199605000-00005.
56. Kakhniashvili, D. G., Griko, N. B., Bulla, L. A. Jr., and Goodman, S. R. (2005). The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp. Biol. Med. (Maywood) 230, 787-792.
57. Kim, Y. R., van't Oever, R., Landayan, M., and Bearden, J. (2003). Automated red blood cell differential analysis on a multi-angle light scatter/fluorescence hematology analyzer. Cytometry B. Clin. Cytom. 56, 43-54. doi: 10.1002/cyto.b.10048.
58. Knowles, D., Tilley, L., Mohandas, N., and Chasis, J. (1997). Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting. Proc. Natl. Acad. Sci. U.S.A. 94, 12969-12974. doi: 10.1073/pnas.94.24.12969.
59. Kriebardis, A., Antonelou, M., Stamoulis, K., and Papassideri, I. (2012). Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? Blood Transfus. 10(Suppl. 2), s25-s38. doi: 10.2450/2012.006S.
60. Kuypers, F. (2008). Red cell membrane lipids in hemoglobinopathies. Curr. Mol. Med. 8, 633-638. doi: 10.2174/156652408786241429.
61. Lackie, J. M. (2007). The Dictionary of Cell & Molecular Biology. Burlington, MA: Academic Press.
62. Lentz, B. (2003). Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog. Lipid Res. 42, 423-438. doi: 10.1016/S0163-7827(03)00025-0.
63. Lew, V. L., and Bookchin, R. M. (2005). Ion transport pathology in the mechanism of sickle cell dehydration. Physiol. Rev. 85, 179-200. doi: 10.1152/physrev.00052.2003.
64. Li, J., Lykotrafitis, G., Dao, M., and Suresh, S. (2007). Cytoskeletal dynamics of human erythrocyte. Proc. Natl. Acad. Sci. U.S.A. 104, 4937-4942. doi: 10.1073/pnas.0700257104.
65. Lutz, H. U., Liu, S. C., and Palek, J. (1977). Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles. J. Cell Biol. 73, 548-560. doi: 10.1083/jcb.73.3.548.
66. Manno, S., Takakuwa, Y., and Mohandas, N. (2002). Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc. Natl. Acad. Sci. U.S.A. 99, 1943-1948. doi: 10.1073/pnas.042688399.
67. Mantel, P. Y., Hoang, A. N., Goldowitz, I., Potashnikova, D., Hamza, B., Vorobjev, I., et al. (2013). Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell. Host Microbe. 13, 521-534. doi: 10.1016/j.chom.2013.04.009.
68. Margetis, P., Antonelou, M., Karababa, F., Loutradi, A., Margaritis, L., and Papassideri, I. (2007). Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations. Blood Cells Mol. Dis. 38, 210-220. doi: 10.1016/j.bcmd.2006.10.163.
69. McMullin, M. (1999). The molecular basis of disorders of red cell enzymes. J. Clin. Pathol. 52, 241-244. doi: 10.1136/jcp.52.4.241.
70. Mebius, R., and Kraal, G. (2005). Structure and function of the spleen. Nat. Rev. Immunol. 5, 606-616. doi: 10.1038/nri1669.
71. Mohandas, N., and Gallagher, P. G. (2008). Red cell membrane: past, present, and future. Blood 112, 3939-3948. doi: 10.1182/blood-2008-07-161166.
72. Mohandas, N., Clark, M. R., Jacobs, M. S., and Shohet, S. B. (1980). Analysis of factors regulating erythrocyte deformability. J. Clin. Invest. 66, 563-573. doi: 10.1172/JCI109888.
73. Mokken, F. C., Kedaria, M., Henny, C. P., Hardeman, M. R., and Gelb, A. W. (1992). The clinical importance of erythrocyte deformability, a hemorrheological parameter. Ann. Hematol. 64, 113-122. doi: 10.1007/BF01697397.
74. Morel, O., Jesel, L., Freyssinet, J., and Toti, F. (2011). Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol. 31, 15-26. doi: 10.1161/ATVBAHA.109.200956.
75. Mozzarelli, A., Hofrichter, J., and Eaton, W. A. (1987). Delay time of hemoglobin s polymerization prevents most cells from sickling in vivo. Science. 237, 500-506. doi: 10.1126/science.3603036.
76. Mullier, F., Bailly, N., Chatelain, C., Chatelain, B., and Dogné, J. (2012). Quantifcation and characterisation of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer. Belg. J. Hematol. 3, 157-160.
77. Nagel, R. L. (2006). "Red cell membrane and transport systems: hereditary disorders," in eLS, (Chichester: John Wiley & Sons, Ltd). doi: 10.1038/npg.els.0002281.
78. Nantakomol, D., Palasuwan, A., Chaowanathikhom, M., Soogarun, S., and Imwong, M. (2012). Red cell and platelet-derived microparticles are increased in G6PD-deficient subjects. Eur. J. Haematol. 89, 423-429. doi: 10.1111/ejh.12010.
79. Pan, B. T., and Johnstone, R. M. (1983). Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967-978. doi: 10.1016/0092-8674(83)90040-5.
80. Pantaleo, A., Ferru, E., Carta, F., Mannu, F., Simula, L. F., Khadjavi, A., et al. (2011). Irreversible ae1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells. PLoS ONE 6:e15847. doi: 10.1371/journal.pone.0015847.
81. Pasini, E., Lutz, H., Mann, M., and Thomas, A. (2010). Red Blood Cell (RBC) Membrane proteomics-Part II: comparative proteomics and RBC patho-physiology. J. Proteomics. 73, 421-435. doi: 10.1016/j.jprot.2009.07.004.
82. Pattanapanyasat, K., Noulsri, E., Fucharoen, S., Lerdwana, S., Lamchiagdhase, P., Siritanaratkul, N., et al. (2004). Flow cytometric quantitation of red blood cell vesicles in Thalassemia. Cytometry B. Clin. Cytom. 57, 23-31. doi: 10.1002/cyto.b.10064.
83. Pearson, H. A., Gallagher, D., Chilcote, R., Sullivan, E., Wilimas, J., Espeland, M., et al. (1985). Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 76, 392-397.
84. Pearson, H. A., McIntosh, S., Ritchey, A. K., Lobel, J. S., Rooks, Y., and Johnston, D. (1979). Developmental aspects of splenic function in sickle cell diseases. Blood 53, 358-365.
85. Perrotta, S., Gallagher, P., and Mohandas, N. (2008). Hereditary spherocytosis. Lancet 372, 1411-1426. doi: 10.1016/S0140-6736(08)61588-3.
86. Poyart, C., and Wajcman, H. (1996). Hemolytic anemias due to hemoglobinopathies. Mol. Aspects Med. 17, 129-142. doi: 10.1016/0098-2997(96)88344-0.
87. Prchal, J. T., and Gregg, X. T. (2005). Red cell enzymes. Hematol. Am. Soc. Hematol. Educ. Program. 19-23. doi: 10.1182/asheducation-2005.1.19.
88. Prudent, M., Tissot, J. D., and Lion, N. (2011). Proteomics of blood and derived products: what's next? Expert Rev. Proteomics 8, 717-737. doi: 10.1586/epr.11.58.
89. Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., et al. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172. doi: 10.1084/jem.183.3.1161.
90. Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383. doi: 10.1083/jcb.201211138.
91. Regev-Rudzki, N., Wilson, D. W., Carvalho, T. G., Sisquella, X., Coleman, B. M., Rug, M., et al. (2013). Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell 153, 1120-1133. doi: 10.1016/j.cell.2013.04.029.
92. Reliene, R., Mariani, M., Zanella, A., Reinhart, W., Ribeiro, M., del Giudice, E., et al. (2002). Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin-and band 3-deficient hereditary spherocytosis. Blood 100, 2208-2215.
93. Sadallah, S., Eken, C., and Schifferli, J. (2008). Erythrocyte-derived ectosomes have immunosuppressive properties. J. Leukoc. Biol. 84, 1316-1325. doi: 10.1189/jlb.0108013.
94. Saniabadi, A., Fisher, T., Lau, C., Bridges, A., Taylor, J., Belch, J., et al. (1992). Dipyridamole increases human red blood cell deformability. Eur. J. Clin. Pharmacol. 42, 651-654. doi: 10.1007/BF00265931.
95. Schauf, B., Mannschreck, B., Becker, S., Dietz, K., Wallwiener, D., and Aydeniz, B. (2004). Evaluation of red blood cell deformability and uterine blood flow in pregnant women with preeclampsia or iugr and reduced uterine blood flow following the intravenous application of magnesium. Hypertens. Pregnancy 23, 331-343. doi: 10.1081/PRG-200030319.
96. Schreier, S., Malheiros, S., and de Paula, E. (2000). Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim. Biophys. Acta. 1508, 210-234. doi: 10.1016/S0304-4157(00)00012-5.
97. Schrier, S. L. (1977). Human erythrocyte membrane enzymes: current status and clinical correlates. Blood 50, 227-237.
98. Shah, M., Bergeron, A., Dong, J., and López, J. (2008). Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 19, 365-372. doi: 10.1080/09537100802054107.
99. Sheetz, M., and Singer, S. (1974). Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc. Natl. Acad. Sci. U.S.A. 71, 4457-4461. doi: 10.1073/pnas.71.11.4457.
100. Silverman, J., and Reiner, N. (2011). Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell. Microbiol. 13, 1-9. doi: 10.1111/j.1462-5822.2010.01537.x.
101. Simpson, R. J., Lim, J. W., Moritz, R. L., and Mathivanan, S. (2009). Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics. 6, 267-283. doi: 10.1586/epr.09.17.
102. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476. doi: 10.1038/ncb1800.
103. Sowemimo-Coker, S., Kovacs, I., Pickles, H., Hedges, A., and Turner, P. (1983). Dipyridamole increases red cell deformability. Br. J. Clin. Pharmacol. 16, 423-425. doi: 10.1111/j.1365-2125.1983.tb02188.x.
104. Spasojevic, I., Maksimovic, V., Zakrzewska, J., and Bacic, G. (2005). Effects of 5-fluorouracil on erythrocytes in relation to its cardiotoxicity: membrane structure and functioning. J. Chem. Inf. Model. 45, 1680-1685. doi: 10.1021/ci0501746.
105. Sprague, R. S., and Ellsworth, M. L. (2012). Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation 19, 430-439. doi: 10.1111/j.1549-8719.2011.00158.x.
106. Stegmayr, B., and Ronquist, G. (1982). Promotive effect on human sperm progressive motility by prostasomes. Urol. Res. 10, 253-257. doi: 10.1007/BF00255932.
107. Steinberg, M. H., Benz, E. J., Adewoye, H. A., and Ebert, B. L. (2008). "Pathobiology of the human erythrocyte and its hemoglobins," in Hematology: Basic Principles and Practice, eds R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, L. E. Silberstein, P. McGlave, and H. Heslop (Philadelphia, PA: Churchill Livingstone), 427-438.
108. Stewart, G. W., Amess, J. A., Eber, S. W., Kingswood, C., Lane, P. A., Smith, B. D., et al. (1996). Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br. J. Haematol. 93, 303-310. doi: 10.1046/j.1365-2141.1996.4881033.x.
109. Stewart, G. W., and Turner, E. J. (1999). The hereditary stomatocytoses and allied disorders: congenital disorders of erythrocyte membrane permeability to Na and K. Baillieres Best Pract. Res. Clin. Haematol. 12, 707-727. doi: 10.1053/beha.1999.0049.
110. Stoya, G., Baumann, E., Junker, U., Hermann, J., and Linss, W. (1997). Flow cytometric analysis of band 3 protein of human erythrocytes. Acta Histochem. 99, 29-36. doi: 10.1016/S0065-1281(97)80005-0.
111. Sustar, V., Bedina-Zavec, A., Stukelj, R., Frank, M., Bobojevic, G., Jansa, R., et al. (2011). Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process. Int. J. Nanomedicine. 6, 2737-2748. doi: 10.2147/IJN.S24537.
112. Svetina, S. (2012). Red blood cell shape and deformability in the context of the functional evolution of its membrane structure. Cell. Mol. Biol. Lett. 17, 171-181. doi: 10.2478/s11658-012-0001-z.
113. Tan, K., and Lip, G. (2005). The potential role of platelet microparticles in atherosclerosis. Thromb. Haemost. 94, 488-492. doi: 10.1160/TH05-03-0201.
114. Thery, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593. doi: 10.1038/nri2567; 10.1038/nri2567.
115. Thomas, S. L., Bouyer, G., Cueff, A., Egee, S., Glogowska, E., and Ollivaux, C. (2011). Ion channels in human red blood cell membrane: actors or relics? Blood Cells Mol. Dis. 46, 261-265. doi: 10.1016/j.bcmd.2011.02.007.
116. Tissot, J., Canellini, G., Rubin, O., Angelillo-Scherrer, A., Delobel, J., Prudent, M., et al. (2013). Blood microvesicles: from proteomics to physiology. Transl. Proteomics 1, 38-52. doi: 10.1016/j.trprot.2013.04.004.
117. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
118. van Wijk, R., and van Solinge, W. (2005). The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 106, 4034-4042. doi: 10.1182/blood-2005-04-1622.
119. Veale, M. F., Healey, G., and Sparrow, R. L. (2011). Effect of additive solutions on red blood cell (RBC) membrane properties of stored RBCs prepared from whole blood held for 24 hours at room temperature. Transfusion 51(Suppl 1), 25S-33S. doi: 10.1111/j.1537-2995.2010.02960.x.
120. Vent-Schmidt, J., Waltz, X., Pichon, A., Hardy-Dessources, M. D., Romana, M., and Connes, P. (2013). Indirect viscosimetric method is less accurate than ektacytometry for the measurement of red blood cell deformability. Clin. Hemorheol. Microcirc. doi: 10.3233/CH-131727. [Epub ahead of print].
121. Wagner, G., Chiu, D., Yee, M., and Lubin, B. (1986). Red cell vesiculation-a common membrane physiologic event. J. Lab. Clin. Med. 108, 315-324.
122. Waugh, S., Willardson, B., Kannan, R., Labotka, R., and Low, P. (1986). Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J. Clin. Invest. 78, 1155-1160. doi: 10.1172/JCI112696.
123. Weiss, E., Rees, D., and Gibson, J. (2011). Role of calcium in phosphatidylserine externalisation in red blood cells from sickle cell patients. Anemia 2011. doi: 10.1155/2011/379894.
124. Werre, J. M., Willekens, F. L., Bosch, F. H., de Haans, L. D., van der Vegt, S. G., van den Bos, A. G., et al. (2004). The red cell revisited-matters of life and death. Cell. Mol. Biol. (Noisy-le-grand) 50, 139-145.
125. Westerman, M., Pizzey, A., Hirschman, J., Cerino, M., Weil-Weiner, Y., Ramotar, P., et al. (2008). Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br. J. Haematol. 142, 126-135. doi: 10.1111/j.1365-2141.2008.07155.x.
126. Wilkinson, D., Turner, E., Parkin, E., Garner, A., Harrison, P., Crawford, M., et al. (2008). Membrane Raft Actin deficiency and altered ca2+-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosis. Biochim. Biophys. Acta. 1778, 125-132. doi: 10.1016/j.bbamem.2007.09.016.
127. Willekens, F. L., Roerdinkholder-Stoelwinder, B., Groenen-Dopp, Y. A., Bos, H. J., Bosman, G. J., van den Bos, A. G., et al. (2003). Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101, 747-751. doi: 10.1182/blood-2002-02-0500.
128. Willekens, F. L., Werre, J. M., Groenen-Dopp, Y. A., Roerdinkholder-Stoelwinder, B., de Pauw, B., and Bosman, G. J. (2008). Erythrocyte vesiculation: a self-protective mechanism? Br. J. Haematol. 141, 549-556. doi: 10.1111/j.1365-2141.2008.07055.x.
129. Willekens, F. L., Werre, J. M., Kruijt, J. K., Roerdinkholder-Stoelwinder, B., Groenen-Dopp, Y. A., van den Bos, A. G., et al. (2005). Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105, 2141-2145. doi: 10.1182/blood-2004-04-1578.
130. Wolf, P. (1967). The nature and significance of platelet products in human plasma. Br. J. Haematol. 13, 269-288. doi: 10.1111/j.1365-2141.1967.tb08741.x.
131. Xiong, Z., Oriss, T. B., Cavaretta, J. P., Rosengart, M. R., and Lee, J. S. (2012). Red cell microparticle enumeration: validation of a flow cytometric approach. Vox Sang. 103, 42-48. doi: 10.1111/j.1423-0410.2011.01577.x.
132. Yeaman, M. R., and Yount, N. Y. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55. doi: 10.1124/pr.55.1.2.
133. Yuditskaya, S., Suffredini, A., and Kato, G. (2010). The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Rev. Proteomics 7, 833-848. doi: 10.1586/epr.10.88.
134. Zanella, A., Fermo, E., Bianchi, P., and Valentini, G. (2005). Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br. J. Haematol. 130, 11-25. doi: 10.1111/j.1365-2141.2005.05527.x.
135. Zwaal, R., and Schroit, A. (1997). Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121-1132.